PROFOUND MEDICAL CORP. Number Of Share Options Granted In Share-based Payment Arrangement
PROFOUND MEDICAL CORP. (PROF) reported Number Of Share Options Granted In Share-based Payment Arrangement of 59.30 thousand Options for the 12-month period ending 2023-12-31, per its 40-F filed 2024-03-07.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement · last filed 2024-03-07
CAD
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|
| 2019-12-31 | 580.44K CAD 40-F · filed 2020-03-03 |
| 2018-12-31 | 199.95K CAD 40-F · filed 2020-03-03 |
USD
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|
| 2020-12-31 | $687.25K 40-F · filed 2021-03-02 |
| 2019-12-31 | $580.44K 40-F · filed 2021-03-02 |
Options
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|---|
| 2023-12-31 | 59.30K Options 40-F · filed 2024-03-07 | |
| 2023-11-16 | 14.30K Options 40-F · filed 2024-03-07 | |
| 2023-09-08 | 7.65K Options 40-F · filed 2024-03-07 | |
| 2023-06-12 | 23.45K Options 40-F · filed 2024-03-07 | |
| 2023-03-22 | 13.90K Options 40-F · filed 2024-03-07 | |
| 2022-12-31 | 29.20K Options 40-F · filed 2024-03-07 | |
| 2022-12-20 | 4.00K Options 40-F · filed 2024-03-07 | |
| 2022-08-15 | 25.20K Options 40-F · filed 2024-03-07 | |
| 2021-12-31 | 698.03K Options 40-F · filed 2023-03-07 | |
| 2021-12-30 | 105.07K Options 40-F · filed 2023-03-07 | |
| 2021-11-15 | 24.50K Options 40-F · filed 2023-03-07 | |
| 2021-06-17 | 1.00K Options 40-F · filed 2023-03-07 | |
| 2021-05-21 | 555.46K Options 40-F · filed 2023-03-07 | |
| 2021-03-11 | 12.00K Options 40-F · filed 2023-03-07 | |
| 2020-12-31 | 687.25K Options 40-F · filed 2022-03-03 | |
| 2020-12-22 | 11.50K Options 40-F · filed 2022-03-03 | |
| 2020-12-15 | 10.00K Options 40-F · filed 2022-03-03 | |
| 2020-11-16 | 84.90K Options 40-F · filed 2022-03-03 | |
| 2020-08-17 | 2.90K Options 40-F · filed 2022-03-03 | |
| 2020-06-08 | 80.00K Options 40-F · filed 2022-03-03 | |
| 2020-05-20 | 481.40K Options 40-F · filed 2022-03-03 | |
| 2020-03-12 | 16.55K Options 40-F · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |